Gard F T Svingen1, Hall Schartum-Hansen2, Eva R Pedersen3, Per M Ueland4, Grethe S Tell5, Gunnar Mellgren6, Pål R Njølstad7, Reinhard Seifert2, Elin Strand3, Therese Karlsson3, Ottar Nygård8. 1. Department of Clinical Science, gard.frodahl.svingen@helse-bergen.no. 2. Department of Heart Disease. 3. Department of Clinical Science. 4. Department of Clinical Science, Laboratory for Clinical Biochemistry. 5. Department of Global Public Health and Primary Care, and Department of Health Registries, Norwegian Institute of Public Health, Bergen, Norway. 6. Department of Clinical Science, Hormone Laboratory, and KG Jebsen Center for Diabetes Research, Department of Pediatrics, University of Bergen, Bergen, Norway; 7. KG Jebsen Center for Diabetes Research, Department of Pediatrics, University of Bergen, Bergen, Norway; Department of Pediatrics, Haukeland University Hospital, Bergen, Norway. 8. Department of Clinical Science, Department of Heart Disease, KG Jebsen Center for Diabetes Research, Department of Pediatrics, University of Bergen, Bergen, Norway;
Abstract
BACKGROUND: Several compounds in the choline oxidation pathway are associated with insulin resistance and prevalent diabetes; however, prospective data are scarce.We explored the relationships between systemic and urinary choline-related metabolites and incident type 2 diabetes in an observational prospective study among Norwegian patients. METHODS: We explored risk associations by logistic regression among 3621 nondiabetic individuals with suspected stable angina pectoris, of whom 3242 provided urine samples. Reclassification of patients was investigated according to continuous net reclassification improvement (NRI >0). RESULTS: After median (25th to 75th percentile) follow-up of 7.5 (6.4-8.7) years, 233 patients (6.4%) were registered with incident type 2 diabetes. In models adjusted for age, sex, and fasting status, plasma betaine was inversely related to new-onset disease [odds ratio (OR) per 1 SD, 0.72; 95% CI, 0.62-0.83; P < 0.00001], whereas positive associations were observed for urine betaine (1.25; 1.09-1.43; P = 0.001), dimethylglycine (1.22; 1.06-1.40; P = 0.007), and sarcosine (1.30; 1.13-1.49; P < 0.001). The associations were maintained in a multivariable model adjusting for body mass index, hemoglobin A1c, urine albumin-to-creatinine ratio, estimated glomerular filtration rate, C-reactive protein, HDL cholesterol, and medications. Plasma betaine and urine sarcosine, the indices most strongly related to incident type 2 diabetes, improved reclassification [NRI >0 (95% CI) 0.33 (0.19-0.47) and 0.16 (0.01-0.31), respectively] and showed good within-person reproducibility. CONCLUSIONS: Systemic and urinary concentrations of several choline metabolites were associated with risk of incident type 2 diabetes, and relevant biomarkers may improve risk prediction.
BACKGROUND: Several compounds in the choline oxidation pathway are associated with insulin resistance and prevalent diabetes; however, prospective data are scarce.We explored the relationships between systemic and urinary choline-related metabolites and incident type 2 diabetes in an observational prospective study among Norwegian patients. METHODS: We explored risk associations by logistic regression among 3621 nondiabetic individuals with suspected stable angina pectoris, of whom 3242 provided urine samples. Reclassification of patients was investigated according to continuous net reclassification improvement (NRI >0). RESULTS: After median (25th to 75th percentile) follow-up of 7.5 (6.4-8.7) years, 233 patients (6.4%) were registered with incident type 2 diabetes. In models adjusted for age, sex, and fasting status, plasma betaine was inversely related to new-onset disease [odds ratio (OR) per 1 SD, 0.72; 95% CI, 0.62-0.83; P < 0.00001], whereas positive associations were observed for urine betaine (1.25; 1.09-1.43; P = 0.001), dimethylglycine (1.22; 1.06-1.40; P = 0.007), and sarcosine (1.30; 1.13-1.49; P < 0.001). The associations were maintained in a multivariable model adjusting for body mass index, hemoglobin A1c, urine albumin-to-creatinine ratio, estimated glomerular filtration rate, C-reactive protein, HDL cholesterol, and medications. Plasma betaine and urine sarcosine, the indices most strongly related to incident type 2 diabetes, improved reclassification [NRI >0 (95% CI) 0.33 (0.19-0.47) and 0.16 (0.01-0.31), respectively] and showed good within-person reproducibility. CONCLUSIONS: Systemic and urinary concentrations of several choline metabolites were associated with risk of incident type 2 diabetes, and relevant biomarkers may improve risk prediction.
Authors: Annie J Roe; Shucha Zhang; Rafeeque A Bhadelia; Elizabeth J Johnson; Alice H Lichtenstein; Gail T Rogers; Irwin H Rosenberg; Caren E Smith; Steven H Zeisel; Tammy M Scott Journal: Am J Clin Nutr Date: 2017-03-29 Impact factor: 7.045
Authors: Ryan O Walters; Esperanza Arias; Antonio Diaz; Emmanuel S Burgos; Fangxia Guan; Simoni Tiano; Kai Mao; Cara L Green; Yungping Qiu; Hardik Shah; Donghai Wang; Adam D Hudgins; Tahmineh Tabrizian; Valeria Tosti; David Shechter; Luigi Fontana; Irwin J Kurland; Nir Barzilai; Ana Maria Cuervo; Daniel E L Promislow; Derek M Huffman Journal: Cell Rep Date: 2018-10-16 Impact factor: 9.423
Authors: Ana Maria Grizales; Mary-Elizabeth Patti; Alexander P Lin; Joshua A Beckman; V Anik Sahni; Emilie Cloutier; Kristen M Fowler; Jonathan M Dreyfuss; Hui Pan; Chisayo Kozuka; Adrienne Lee; Rita Basu; David M Pober; Robert E Gerszten; Allison B Goldfine Journal: J Clin Endocrinol Metab Date: 2018-08-01 Impact factor: 5.958
Authors: Kathryn N Porter Starr; Margery A Connelly; Melissa C Orenduff; Shelley R McDonald; Richard Sloane; Kim M Huffman; William E Kraus; Connie W Bales Journal: J Clin Lipidol Date: 2019-10-02 Impact factor: 5.365